Company Search:
Advanced Search
Sponsored Links
Cocokara Fine Incorporated Company Snapshot
Cocokara Fine Incorporated operates within the Drug stores and proprietary stores sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cocokara Fine Incorporated with three other companies in this sector in Japan: Sugi Holdings Company Limited (2017 sales of 430.80 billion Japanese Yen [US$3.90 billion] of which 100% was Drug Compounding Business), Cosmos Pharmaceutical Corp (502.73 billion Japanese Yen [US$4.55 billion] of which 100% was Pharmaceuticals & Cosmetics), and Cawachi Limited (266.42 billion Japanese Yen [US$2.41 billion] of which 46% was General food).

Sales Analysis. During the year ended March of 2017, sales at Cocokara Fine Incorporated were ¥377.20 billion (US$3.41 billion). This is a very small increase of 1.1% versus 2016, when the company's sales were ¥373.28 billion. Sales of Care saw an increase that was more than double the company's growth rate: sales were up 7.4% in 2017, from ¥2.24 billion to ¥2.41 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cocokara Fine Incorporated
  Stock Performance Chart for Cocokara Fine Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 6,720.00
(Figures in Japanese Yen)
1 Week -7.3%   13 Weeks -8.6%  
4 Weeks 5.3%   52 Weeks 50.5%  
Cocokara Fine Incorporated Key Data:
  Ticker: 3098 Country: Japan
  Exchanges: FRA TYO Major Industry: Food & Drug Retailing
    Sub Industry: Drug Stores & Proprietary Stores
  2017 Sales 377,203,000,000
(Year Ending Jan 2018).
Employees: 6,010
  Currency: Japanese Yen Market Cap: 161,431,381,440
  Fiscal Yr Ends: March Shares Outstanding: 24,022,527
  Share Type: Common Closely Held Shares: 5,523,856
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.